Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Nanophase Technologies Stock News

NANXOTCQB

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$2.84

-0.03-1.05%

Pre-Market: Feb 14, 9:27 AM EDT

Q4 2024 earnings announcement after the market close today

Conference call scheduled tomorrow at 8:00 AM Click to view the webcast

Nanophase Technologies (NANX) Forecast

News

Earnings Nanophase Technologies (NANX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Nanophase Technologies Stock News | OTC:NANX | Benzinga

Get the latest news on Nanophase Technologies stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Nanophase Technologies performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, October 30, 2024

Nanophase Technologies Q3 GAAP EPS $0.04 Up F...
Benzinga Newsdesk

Tuesday, September 10, 2024

System1 And 2 Other Stocks Under $2 Executives Are Buying
Avi Kapoor

Friday, September 06, 2024

Red Robin And 3 Other Stocks Under $5 Executives Are Buying
Avi Kapoor

Friday, August 23, 2024

CPI Aerostructures And 2 Other Stocks Under $3 Executives Are Buying
Avi Kapoor

Tuesday, August 06, 2024

Nanophase Technologies Q2 EPS $0.01, Same YoY...
Benzinga Newsdesk

Wednesday, June 26, 2024

NeuroBo Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying
Avi Kapoor

Thursday, June 13, 2024

Assertio Holdings And 2 Other Penny Stocks Insiders Are Buying
Avi Kapoor

Tuesday, May 28, 2024

$75M Bet On Aurora Innovation? Check Out These 5 Penny Stocks Insiders Are Aggressively Buying
Avi Kapoor

Tuesday, May 14, 2024

Zomedica And 3 Other Stocks Under $3 Insiders Are Buying
Avi Kapoor

Wednesday, February 14, 2024

Retractable Technologies And 2 Other Stocks Under $5 Insiders Are Buying
Avi Kapoor

Tuesday, February 13, 2024

Lumen Technologies And 2 Other Stocks Under $2 Insiders Are Buying
Avi Kapoor

Monday, November 13, 2023

Nanophase Technologies Q3 2023 Gaap EPS $(0.0...
Benzinga Newsdesk

Thursday, August 24, 2023

Kingstone Companies And 3 Other Stocks Under $2 Insiders Are Buying
Lisa Levin

Wednesday, August 02, 2023

Nanophase Technologies Q2 EPS $0.01, Sales $1...
Benzinga Newsdesk

Tuesday, June 06, 2023

55K Reasons To Be Bullish On Nanophase Technologies Stock
Benzinga Insights
Over $72M Bet On This Biotechnology Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
Lisa Levin

Wednesday, December 21, 2022

$1 Million Bet On BioCardia? Check Out These 4 Penny Stocks Insiders Are Buying
Lisa Levin

Friday, December 16, 2022

4 Penny Stocks Insiders Are Buying: Getaround, Corvus Pharmaceuticals And More
Lisa Levin

Thursday, August 06, 2020

Nanophase Technologies Q2 EPS $0.01 Up From $...
Benzinga Newsdesk

Monday, October 21, 2019

Stocks That Hit 52-Week Lows On Monday
Lisa Levin

Monday, October 07, 2019

Stocks That Hit 52-Week Lows Of Monday
Lisa Levin

Wednesday, August 28, 2019

Nanophase Technologies Q2 EPS $(0.02) Down Fr...
Benzinga Newsdesk

Thursday, August 24, 2017

Companies Holding Shareholder Meetings Today ...
Benzinga

Wednesday, February 24, 2016

Nanophase Reports Q4 EPS $(0.01), Sales $2.3M
Benzinga

Monday, March 02, 2015

Nanophase Technologies Dir Whitmore Buys 100,...
Benzinga

Wednesday, March 07, 2012

Nanophase To Delist to OTCQB Marketplace on March 20th
Benzinga

Tuesday, September 20, 2011

Nanophase Receives Compliance Notice From NASDAQ
Benzinga

Monday, May 09, 2011

Top Chemical Manufacturing Stocks pick to buy- FSI, VHI, SMG, LXU, TNH, SHI, BAK, CF, RTK, GRA, NANX…
Benzinga

Thursday, January 13, 2011

Nanophase Appoints W. Ed Tyler to Its Board
Benzinga

Tuesday, July 06, 2010

Mid-Day Market Movers (NEXMD, NANX, BWEN, CGL-A)
Benzinga

Thursday, May 27, 2010

Top Performing Industries For May 27 (SBSA, NTAP, NANX, SCHN)
Benzinga

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved